Document is current
Any future updates will be listed below
-
Authors
Mekontso Dessap, Armand https://orcid.org/0000-0001-5961-5577
Dauger, Stephane
Khellaf, Mehdi
Agbakou, Maite
Agut, Sophie
Angoulvant, François
Arlet, Jean-Benoît
Aubron, Cécile
Baudin, Florent
Boissier, Florence
Bounaud, Nicolas
Catoire, Pierre
Cecchini, Jérôme
Chaiba, Djamila
Chauvin, Anthony
Chocron, Richard
Douay, Benedicte
Douillet, Delphine
Elenga, Narcisse
Flechelle, Olivier
Gendreau, Ségolène
Goddet, Sybille
Guenezan, Jeremy
Habibi, Anoosha
Heilbronner, Claire
Koehl, Bérengère
Le Borgne, Pierrick
Le Conte, Philippe
Legras, Annick
Levy, Michael
Maitre, Bernard
Oberlin, Mathieu
Oualha, Mehdi
Peschanski, Nicolas
Pirenne, France
Pondarre, Corinne
Rambaud, Jérôme
Razazi, Keyvan
Rousseau, Geoffroy
Schirmann, Aurélie
Thuret, Isabelle
Valentino, Ruddy
Voiriot, Guillaume
Villoing, Barbara
Grimaud, Marion
Jean, Sandrine
- License Information
-
More Information
Article History
Received: 27 January 2025
Accepted: 16 April 2025
First Online: 29 May 2025
Declarations
:
: Not applicable.
: Not applicable.
: MEKONTSO DESSAP Armand reports grants and fees from Addmedica, Fisher & Paykel Healthcare, and Orkyn. RAZAZI Keyvan has received lecture fees from MSD, Shionogi, and a travel grant from Pfizer outside the submitted work. PIRENNE France has received honoraria from GRIFOLS. ARLET Jean-Benoît declares that he has received research funding from Theravia, GBT-Pfizer, Novartis, and Vertex, and has been supported at scientific conferences by Novartis France, GBT. AUBRON Cécile has received lecture fees from CSL-VIFOR, Cereus and MSD. BAUDIN Florent reports a relationship with Dräger Medical, Fisher & Paykel Healthcare, Sedana Medical that includes non-financial support and travel reimbursement. ELENGA Narcisse has received consultant fees from THERAVIA. GENDREAU Ségolène reports support from Pharma Dom for attending a meeting, outside the submitted work. HABIBI Anoosha has received fees as a consulted for Novartis, GBT-Pfizer and Theravia, and attended conferences sponsored by Novartis and GBT-Pfizer. PESCHANSKI Nicolas reports fees from Fisher&Paykel Healthcare SAS. PONDARRE Corinne reports honoraria for Novartis and expert consultancy for Addmedica, Global Blood Therapeutics and Pfizer. MAITRE Bernard reports research funding from Ikaria (ex iNOTherapeutics) and Leo Pharma (clinical trials in acute chest syndrome). THURET Isabelle reports honoraria from Pfizer and Vertex as menber of advisory board. Other authors declared no competing interest.
